Related Experiment Video

Updated: Feb 17, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.7K

[Coronary revascularization in patients with ST-elevation myocardial infarction and multivessel disease]

Giulia Bugani1, Valerio Lanzillotti2, Elisa Filippini2

  • 1U.O. Cardiologia, Azienda Ospedaliera Universitaria S. Anna, Cona (FE).

Giornale Italiano Di Cardiologia (2006)
|December 1, 2017
PubMed

Insights

Complete revascularization in ST-elevation myocardial infarction (STEMI) patients with multivessel coronary artery disease may reduce major adverse cardiac events. Optimization of medical therapy remains crucial, while complete PCI guided by ischemia may further improve outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Research

Background:

  • ST-elevation myocardial infarction (STEMI) patients frequently present with multivessel coronary artery disease (CAD).
  • The optimal strategy for managing non-culprit lesions in STEMI patients with multivessel CAD remains debated.
  • Multivessel CAD is associated with poorer outcomes compared to single-vessel CAD.

Purpose of the Study:

  • To review current evidence comparing culprit-only revascularization versus complete revascularization in STEMI patients with multivessel CAD.
  • To discuss the controversies surrounding the timing and methods of complete revascularization.
  • To highlight the role of medical therapy and potential benefits of ischemia-guided complete revascularization.

Main Methods:

  • Review of recent randomized controlled trials and meta-analyses.
  • Comparison of complete revascularization strategies (culprit-only vs. complete PCI) in STEMI patients.
  • Analysis of data regarding major adverse cardiac events, mortality, and reinfarction.

Main Results:

  • The majority of studies suggest a potential benefit of complete revascularization in reducing major adverse cardiac events.
  • Data on long-term mortality and reinfarction after complete revascularization are still limited.
  • Controversies persist regarding the optimal timing (during primary PCI or staged PCI) and lesion assessment methods (angiographic vs. functional).

Conclusions:

  • Optimization of medical therapy, including newer antiplatelet agents and aggressive lipid-lowering, is essential for STEMI patients with multivessel CAD.
  • Complete coronary revascularization guided by ischemia assessment, tailored to patient-specific factors, may offer further improvements in outcomes.
  • Further research is needed to clarify long-term outcomes and optimal strategies for complete revascularization.

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.3K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.4K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
313
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
738
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K